Home › Research › Down syndrome and Alzheimer's
Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects
Tiano L, Padella L, Carnevali P, Gabrielli O, Bruge F, Principi F, Littarru GP.. BioFactors (Oxford, England), 2008-01-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Down syndrome (DS) is a chromosomal abnormality (trisomy 21) associated with mental retardation and Alzheimer-like dementia, characteristic change of the individual's phenotype and premature ageing. Oxidative stress is known to play a major role in this pathology since a gene dose effect leads to elevated ratio of superoxide dismutase to catalase/glutathione peroxidase compared to controls in all age categories suggesting that oxidative imbalance contributes to the clinical manifestation of DS. Hyperuricemia is another feature of DS that has an interesting relationship with oxidative stress since uric acid represents an important free radical scavenger. However its formation is connected to the conversion of Xanthine dehydrogenase (XDH) to Xanthine oxidase (XO) which leads to concomitant production of free radicals. Here we report that plasma samples from DS patients in pediatric age, despite an increased total antioxidant capacity, largely due to elevated Uric acid content (UA), present significantly elevated markers of oxidative damage such as increased allantoin levels. Moreover DS plasma samples do not differ from healthy control ones in terms of Coenzyme Q10 and susceptibility to peroxidative stimuli. On the contrary, lymphocyte and platelet CoQ10 content was significantly lower in DS patients, a fact that might underlie oxidative imbalance at a cellular level.
What this study adds
Evidence grade: Low
This study found signs of oxidative damage in blood from children with Down syndrome, along with lower coenzyme Q10 levels inside their cells. The authors link oxidative imbalance to the clinical features of Down syndrome, but no treatment or prevention was tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Tiano, L., Padella, L., Carnevali, P., Gabrielli, O., Bruge, F., Principi, F., et al. (2008). Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects. BioFactors (Oxford, England). https://doi.org/10.1002/biof.5520320119
Vancouver
Tiano L, Padella L, Carnevali P, Gabrielli O, Bruge F, Principi F, et al. Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects. BioFactors (Oxford, England). 2008. doi:10.1002/biof.5520320119. PMID: 19096112.
BibTeX
@article{tiano2008-19096112,
author = {Tiano, L. and Padella, L. and Carnevali, P. and Gabrielli, O. and Bruge, F. and Principi, F. and Littarru, G. P.},
title = {{Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects}},
journal = {BioFactors (Oxford, England)},
year = {2008},
doi = {10.1002/biof.5520320119},
pmid = {19096112},
url = {https://doi.org/10.1002/biof.5520320119}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Down syndrome (DS) is a chromosomal abnormality (trisomy 21) associated with mental retardation and Alzheimer-like dementia, characteristic change of the individual's phenotype and premature ageing.
- Oxidative stress is known to play a major role in this pathology since a gene dose effect leads to elevated ratio of superoxide dismutase to catalase/glutathione peroxidase compared to controls in all age categories suggesting that oxidative imbalance contributes to the clinical manifestation of DS.
- Here we report that plasma samples from DS patients in pediatric age, despite an increased total antioxidant capacity, largely due to elevated Uric acid content (UA), present significantly elevated markers of oxidative damage such as increased allantoin levels.
- On the contrary, lymphocyte and platelet CoQ10 content was significantly lower in DS patients, a fact that might underlie oxidative imbalance at a cellular level.
Why it matters
This study found signs of oxidative damage in blood from children with Down syndrome, along with lower coenzyme Q10 levels inside their cells. The authors link oxidative imbalance to the clinical features of Down syndrome, but no treatment or prevention was tested.
Study details
- Evidence strengthLow
How this study scored 31/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (BioFactors (Oxford, England)) |
| Journal's citation record | 1 / 4 | BioFactors: journal h-index 134 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2008 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 32 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.6 citations a year over 20 year(s) since 2008 |
| Impact for its field and year | 2 / 6 | Cited 1.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Gian Paolo Littarru: h-index 37 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Marche Polytechnic University: institution h-index 419 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 19096112) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 31 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.